Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03829462
Title Assessing a Regorafenib-irinotecan Combination Versus Regorafenib Alone in Metastatic Colorectal Cancer Patients (NEXT-REGIRI)
Acronym NEXT-REGIRI
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Institut du Cancer de Montpellier - Val d'Aurelle
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Centre Antoine Lacassagne Nice Alpes-Maritimes 06189 France Details
Centre François Baclesse Caen Basse-Normandie 14000 France Details
Hôpital Pontchaillou Rennes Ile Et Vilaine 35000 France Details
Hôpital Robert Debré Reims Marne 51100 France Details
Institut Godinot Reims Marne 51100 France Details
Hôpital Saint-Jean Perpignan Pyrénées-orientales 66000 France Details
Centre Léon Bérard Lyon Rhône 69008 France Details
Hôpital privé Jean Mermoz Lyon Rhône 69008 France Details
Institut Gustave Roussy Villejuif Val De Marne 94800 France Details
CRLC Val d'Aurelle-Paul Lamarque Montpellier 34298 France Details
Hôpital Européen Georges Pompidou Paris 75015 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field